NEDD4 family E3 ligases in osteoporosis: mechanisms and emerging potential therapeutic targets

Abstract Osteoporosis is a systemic skeletal disorder characterized by reduced bone density and an increased risk of fractures, particularly prevalent in the aging population. Osteoporotic complications, including vertebral compression fractures, hip fractures, and distal forearm fractures, affect o...

Full description

Saved in:
Bibliographic Details
Main Authors: Heng Wu, Junhui Zuo, Yu Dai, Hairui Li, Song Wang
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Journal of Orthopaedic Surgery and Research
Subjects:
Online Access:https://doi.org/10.1186/s13018-025-05517-5
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832585591993139200
author Heng Wu
Junhui Zuo
Yu Dai
Hairui Li
Song Wang
author_facet Heng Wu
Junhui Zuo
Yu Dai
Hairui Li
Song Wang
author_sort Heng Wu
collection DOAJ
description Abstract Osteoporosis is a systemic skeletal disorder characterized by reduced bone density and an increased risk of fractures, particularly prevalent in the aging population. Osteoporotic complications, including vertebral compression fractures, hip fractures, and distal forearm fractures, affect over 8.9 million individuals globally, placing a significant economic strain on healthcare systems. Recent advances have expanded our understanding of the mechanisms underlying osteoporosis, particularly the intricate regulatory networks involved in bone metabolism. A central player in these processes is ubiquitin-mediated proteasomal degradation, a crucial post-translational modification system that involves ubiquitin, the ubiquitin-activating enzyme (E1), ubiquitin-conjugating enzyme (E2), ubiquitin ligase (E3), deubiquitinating enzymes, and the proteasome. Among the various E3 ligases, the NEDD4 family has emerged as a key regulator of both bone development and osteoporotic pathology. This review delineates the role of NEDD4 family in osteoporosis and identifies potential drug targets within these pathways, offering insights into novel therapeutic approaches for osteoporosis through targeted intervention.
format Article
id doaj-art-bffba2689c854f51b83a8d0820e01574
institution Kabale University
issn 1749-799X
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Journal of Orthopaedic Surgery and Research
spelling doaj-art-bffba2689c854f51b83a8d0820e015742025-01-26T12:43:19ZengBMCJournal of Orthopaedic Surgery and Research1749-799X2025-01-0120111210.1186/s13018-025-05517-5NEDD4 family E3 ligases in osteoporosis: mechanisms and emerging potential therapeutic targetsHeng Wu0Junhui Zuo1Yu Dai2Hairui Li3Song Wang4Department of Orthopedics, the Affiliated Hospital of Southwest Medical UniversityDepartment of Orthopedics, the Affiliated Hospital of Southwest Medical UniversityDepartment of Oncology, the Affiliated Hospital of Southwest Medical UniversityDepartment of Urology, West China Hospital of Sichuan UniversityDepartment of Orthopedics, the Affiliated Hospital of Southwest Medical UniversityAbstract Osteoporosis is a systemic skeletal disorder characterized by reduced bone density and an increased risk of fractures, particularly prevalent in the aging population. Osteoporotic complications, including vertebral compression fractures, hip fractures, and distal forearm fractures, affect over 8.9 million individuals globally, placing a significant economic strain on healthcare systems. Recent advances have expanded our understanding of the mechanisms underlying osteoporosis, particularly the intricate regulatory networks involved in bone metabolism. A central player in these processes is ubiquitin-mediated proteasomal degradation, a crucial post-translational modification system that involves ubiquitin, the ubiquitin-activating enzyme (E1), ubiquitin-conjugating enzyme (E2), ubiquitin ligase (E3), deubiquitinating enzymes, and the proteasome. Among the various E3 ligases, the NEDD4 family has emerged as a key regulator of both bone development and osteoporotic pathology. This review delineates the role of NEDD4 family in osteoporosis and identifies potential drug targets within these pathways, offering insights into novel therapeutic approaches for osteoporosis through targeted intervention.https://doi.org/10.1186/s13018-025-05517-5OsteoporosisUbiquitinationE3 ubiquitin ligaseNEDD4 ubiquitin ligase familyTherapeutics
spellingShingle Heng Wu
Junhui Zuo
Yu Dai
Hairui Li
Song Wang
NEDD4 family E3 ligases in osteoporosis: mechanisms and emerging potential therapeutic targets
Journal of Orthopaedic Surgery and Research
Osteoporosis
Ubiquitination
E3 ubiquitin ligase
NEDD4 ubiquitin ligase family
Therapeutics
title NEDD4 family E3 ligases in osteoporosis: mechanisms and emerging potential therapeutic targets
title_full NEDD4 family E3 ligases in osteoporosis: mechanisms and emerging potential therapeutic targets
title_fullStr NEDD4 family E3 ligases in osteoporosis: mechanisms and emerging potential therapeutic targets
title_full_unstemmed NEDD4 family E3 ligases in osteoporosis: mechanisms and emerging potential therapeutic targets
title_short NEDD4 family E3 ligases in osteoporosis: mechanisms and emerging potential therapeutic targets
title_sort nedd4 family e3 ligases in osteoporosis mechanisms and emerging potential therapeutic targets
topic Osteoporosis
Ubiquitination
E3 ubiquitin ligase
NEDD4 ubiquitin ligase family
Therapeutics
url https://doi.org/10.1186/s13018-025-05517-5
work_keys_str_mv AT hengwu nedd4familye3ligasesinosteoporosismechanismsandemergingpotentialtherapeutictargets
AT junhuizuo nedd4familye3ligasesinosteoporosismechanismsandemergingpotentialtherapeutictargets
AT yudai nedd4familye3ligasesinosteoporosismechanismsandemergingpotentialtherapeutictargets
AT hairuili nedd4familye3ligasesinosteoporosismechanismsandemergingpotentialtherapeutictargets
AT songwang nedd4familye3ligasesinosteoporosismechanismsandemergingpotentialtherapeutictargets